These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24513020)

  • 1. Novel action of metformin in the prevention of haloperidol-induced catalepsy in mice: Potential in the treatment of Parkinson's disease?
    Adedeji HA; Ishola IO; Adeyemi OO
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():245-251. PubMed ID: 24513020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinpocetine prevents haloperidol-induced cognitive and working memory deficits through attenuation of oxidative and nitrosative stress in mice.
    Ishola IO; Isaac AI; Adeyemi OO
    Niger J Physiol Sci; 2020 Dec; 35(2):203-208. PubMed ID: 34009202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease.
    Azam F; Barodia SK; Anwer T; Alam MM
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):808-17. PubMed ID: 18846462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of hesperetin against haloperidol-induced orofacial dyskinesia and catalepsy in rats.
    Dhingra D; Goswami S; Gahalain N
    Nutr Neurosci; 2018 Nov; 21(9):667-675. PubMed ID: 28641484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
    Patil SP; Jain PD; Ghumatkar PJ; Tambe R; Sathaye S
    Neuroscience; 2014 Sep; 277():747-54. PubMed ID: 25108167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol-induced parkinsonism is attenuated by varenicline in mice.
    Sharma AK; Gupta S; Patel RK; Wardhan N
    J Basic Clin Physiol Pharmacol; 2018 Jul; 29(4):395-401. PubMed ID: 29634484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice.
    Abdel-Salam OM; El-Sayed El-Shamarka M; Salem NA; El-Din M Gaafar A
    EXCLI J; 2012; 11():45-58. PubMed ID: 27366134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation.
    Ishola IO; Akinyede AA; Adeluwa TP; Micah C
    Metab Brain Dis; 2018 Oct; 33(5):1493-1500. PubMed ID: 29855979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of toxicological and antioxidant potential of Nardostachys jatamansi in reversing haloperidol-induced catalepsy in rats.
    Rasheed AS; Venkataraman S; Jayaveera KN; Fazil AM; Yasodha KJ; Aleem MA; Mohammed M; Khaja Z; Ushasri B; Pradeep HA; Ibrahim M
    Int J Gen Med; 2010 May; 3():127-36. PubMed ID: 20531975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental validation of Vitex negundo leaves hydroalcoholic extract for neuroprotection in haloperidol induced parkinson's disease in rat.
    Vannur A; Biradar PR; Patil V
    Metab Brain Dis; 2022 Feb; 37(2):411-426. PubMed ID: 35023027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice.
    Azam F; Alkskas IA; Ahmed MA
    Eur J Med Chem; 2009 Oct; 44(10):3889-97. PubMed ID: 19447524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease.
    Khurana N; Gajbhiye A
    Neurotoxicology; 2013 Dec; 39():57-64. PubMed ID: 23994302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol-induced catalepsy: a model for screening antidepressants effective in treatment of depression with Parkinson's disease.
    Khisti RT; Mandhane SN; Chopde CT
    Indian J Exp Biol; 1997 Dec; 35(12):1297-301. PubMed ID: 9567763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Intracerebral Aminophylline Dosing on Catalepsy and Gait in an Animal Model of Parkinson's Disease.
    de Moraes Santos Corrêa É; Christofoletti G; de Souza AS
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of haloperidol-induced swim impairment in L-dopa and caffeine treated mice: a pre-clinical model to study Parkinson's disease.
    Luthra PM; Barodia SK; Raghubir R
    J Neurosci Methods; 2009 Apr; 178(2):284-90. PubMed ID: 19146880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine withdrawal retains anticataleptic activity but Withania somnifera withdrawal potentiates haloperidol-induced catalepsy in mice.
    Kasture S; Barhate S; Mohan M; Ballero M; Sanna C; Maxia A
    Nat Prod Res; 2009; 23(8):724-8. PubMed ID: 19418355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine.
    Góngora-Alfaro JL; Moo-Puc RE; Villanueva-Toledo JR; Alvarez-Cervera FJ; Bata-García JL; Heredia-López FJ; Pineda JC
    Neurosci Lett; 2009 Oct; 463(3):210-4. PubMed ID: 19654037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of NR-ANX-C (a polyherbal formulation) on haloperidol induced catalepsy in albino mice.
    Nair V; Arjuman A; Dorababu P; Gopalakrishna HN; Chakradhar Rao U; Mohan L
    Indian J Med Res; 2007 Nov; 126(5):480-4. PubMed ID: 18160755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Withania somnifera root extract on haloperidol-induced catalepsy in albino mice.
    Nair V; Arjuman A; Gopalakrishna HN; Nandini M
    Phytother Res; 2008 Feb; 22(2):243-6. PubMed ID: 17886228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms.
    Invernizzi RW; Garavaglia C; Samanin R
    Neuropsychopharmacology; 2003 May; 28(5):872-9. PubMed ID: 12644843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.